<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01308073</url>
  </required_header>
  <id_info>
    <org_study_id>EMIC2_2011_02_03</org_study_id>
    <nct_id>NCT01308073</nct_id>
  </id_info>
  <brief_title>Stability of Middle Molecule Clearance</brief_title>
  <acronym>EMIC2</acronym>
  <official_title>Long-time Stability of Middle Molecule Clearance During CI-Ca CVVHD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinik für Anästhesiologie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fresenius Medical Care Deutschland GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to show, whether all middle molecules are included in the clearance and
      whether this clearance is stable until 72 hours.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A better middle molecule clearance has been shown until 24 hours of duration. The
      investigators will extend our observations until 72 hours.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clearance of Urea</measure>
    <time_frame>up to 72 h</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clearance of Cystatin C</measure>
    <time_frame>up to 72 h</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clearance of creatinine</measure>
    <time_frame>up to 72 h</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clearance of Beta2-Microglobulin</measure>
    <time_frame>up to 72 h</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clearance of Osteocalcin</measure>
    <time_frame>up to 72 h</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Free light chains kappa of Immunoglobulins</measure>
    <time_frame>up to 72 h</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clearance of albumin</measure>
    <time_frame>up to 72 h</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean arterial pressure</measure>
    <time_frame>up to 72 h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vasopressor requirement</measure>
    <time_frame>up to 72 h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>up to 72 h</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">15</enrollment>
  <condition>Continuous Hemodialysis</condition>
  <arm_group>
    <arm_group_label>EMIC 2 dialysis</arm_group_label>
    <description>Patients on ICU requiring dialysis for acute renal insufficiency</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hemodialysis with EMIC 2 filters</intervention_name>
    <description>Patients with indication for routine continuous hemodialysis due to acute renal insufficiency</description>
    <arm_group_label>EMIC 2 dialysis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients of surgical intensive care unit
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  informed consent

          -  age&gt;18 years

          -  acute renal insufficiency with indication for continuous hemodialysis, according to
             RILFE classification F: serum creatinine increase &gt; 3-fold or serum creatinine &gt;
             4mg/dl with acute increase of &gt;0,5mg/dl Urine Output &lt;0,3mg/kg/h for 24 h or anuria
             for 12 h

          -  body weight:60-80kg

          -  anticoagulation with citrate possible and indicated

          -  Dose for hemodialysis of 2l/h

        Exclusion Criteria:

          -  participation in another clinical trial within on month prior to this study

          -  pregnancy or brest feeding

          -  septic shock

          -  interference with cystatin-C

               1. haemolysis &lt;1g/dl

               2. Bilirubin&lt;9mg/dl

               3. Triglyceride &gt;700mg/dl

               4. rheumatoid factor &gt; 300kIU/l
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Detlef Kindgen-Milles, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinik für Anästhesiologie Universitätsklinikum Düsseldorf Heinrich-Heine Universität</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Intensivstation ZOM1 Klinik für Anästhesiologie Universitätsklinikum Düsseldorf</name>
      <address>
        <city>Duesseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2011</study_first_submitted>
  <study_first_submitted_qc>March 2, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2011</study_first_posted>
  <last_update_submitted>December 18, 2014</last_update_submitted>
  <last_update_submitted_qc>December 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik für Anästhesiologie</investigator_full_name>
    <investigator_title>Leiter Interdisziplinäre Operative Intensivstation ZOM-I</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

